Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLoose stools and diarrhoea are among the most common side effects of tirzepatide, particularly in the first few weeks of treatment or after a dose increase. They affect a meaningful proportion of people who start Mounjaro, but they are usually temporary and manageable with straightforward adjustments to food, hydration and timing. Understanding why this happens — and what genuinely helps — makes a real difference to whether you stay on track. Because tirzepatide is a prescription-only medicine that requires clinical oversight, any side effects that are severe, persistent or worrying should be discussed with your prescribing team rather than managed alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A common reaction when diarrhoea starts is to assume something has gone wrong, that the medicine doesn't suit you, or that you should stop immediately. That conclusion is almost always premature. Tirzepatide slows gastric emptying and alters gut-hormone signalling across two receptors (GIP and GLP-1), which means the digestive system genuinely needs time to recalibrate. The NHS medicine page for tirzepatide lists diarrhoea as a common side effect, expected in some people, and not a signal that treatment should automatically end.
The first few weeks at each dose level are the adjustment window. Most people find that loose stools settle considerably once the body has adapted, often within two to four weeks. Stopping prematurely, or reducing your dose without guidance, disrupts that process and may leave you cycling through the same discomfort repeatedly. If you are finding the side effects hard to manage, the right move is a conversation with your prescribing team, not a unilateral decision to stop. Our prescribers at nume discuss side-effect management as part of the consultation and every subsequent review.
What the evidence does not support is the idea that diarrhoea at the beginning predicts long-term intolerance. Many people who experience significant early symptoms are comfortably established on their maintenance dose within a couple of months.
Diet choices are the lever most people have the most immediate control over. Fatty, rich or heavily processed foods increase the speed at which stomach contents move through the gut, and since tirzepatide already alters that transit time, combining the two amplifies the effect. Temporarily cutting back on high-fat meals, fried food and alcohol often reduces urgency noticeably. Small, frequent meals put less pressure on the digestive system than large ones.
Hydration matters more than most people realise. Loose stools can deplete fluids faster than expected, and mild dehydration itself worsens gut irritability. Plain water, diluted squash and oral rehydration sachets are more useful than caffeine-heavy drinks, which can speed gut transit further. Some people find that a plain biscuit or a small serving of starchy food alongside their morning coffee makes a practical difference to their day, it is the kind of simple adjustment that costs nothing.
Timing your injection on a day when you can rest for the following 24 hours, if your schedule allows, can help during the early dose-adjustment period. Soluble fibre (found in oats, bananas and cooked vegetables) can help bulk the stool without straining the gut. For short-term symptomatic relief, loperamide (sold as Imodium) is an option, but it should be used as a bridge, not a long-term fix, and is worth discussing with your prescriber before regular use. Our dedicated page on practical ways to stop diarrhoea from Mounjaro covers these points in more detail alongside full guidance on managing diarrhoea specifically linked to tirzepatide, as does our page on diarrhoea specifically linked to tirzepatide.
Most diarrhoea on tirzepatide is mild to moderate and resolves without intervention beyond the adjustments above. There are situations, though, that need proper medical attention and should not be managed at home.
Get help promptly if you experience severe stomach pain that spreads to your back, this can be a sign of pancreatitis, which the MHRA highlighted in a Drug Safety Update for GLP-1 medicines. Pancreatitis is uncommon but serious; do not wait to see if the pain eases on its own. Similarly, seek medical help if diarrhoea is so frequent or profuse that you cannot stay hydrated, if there is blood in your stool, or if you feel significantly unwell alongside the gut symptoms. Signs of dehydration (dizziness when standing, very dark urine, confusion) also warrant prompt attention.
If diarrhoea continues beyond four to six weeks at a stable dose without improvement, or if it returns severely after a period of calm, speak to your prescriber. A dose pause or slower titration may be appropriate. The full side-effect profile of Mounjaro covers the complete range of symptoms to be aware of across treatment. You can also flag any suspected side effect through the MHRA's Yellow Card scheme, this is open to patients as well as clinicians, and the data informs national safety decisions.
Before any prescription is issued, a GPhC-registered Independent Prescriber personally reviews your medical history, current medicines and any conditions that might affect how you tolerate tirzepatide. That review is not automated. Side-effect management (including what to do if diarrhoea or other GI symptoms develop) is part of what the consultation covers, and our clinical team remains available seven days a week for aftercare.
People who transfer to nume from another provider, or who are asking about diarrhoea they are already experiencing on Mounjaro, can raise that in the consultation form so the prescriber has the full picture before making any clinical decision. The broader evidence on tirzepatide and diarrhoea may also be useful reading alongside this page. If you are thinking about starting treatment and want to understand the side-effect landscape first, our free consultation is the right place to begin, there is no obligation, and your suitability is assessed on clinical grounds, not assumptions.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.